This report highlights our work since January to help communities build capacity, inform the public about the safety and efficacy of COVID-19 vaccines, and spread the word about the importance of therapeutics in treating the virus. It also provides a snapshot of our efforts to shore up disaster and disease outbreak responses in cities throughout the nation and how we are strengthening the healthcare supply chain through our public/private partnerships.
We’re answering questions on COVID-19 vaccine safety and efficacy and shedding light on the vaccine development process. These publicly available resources can help communities dispel the myths and rumors surrounding COVID-19 vaccines to encourage more people to become immunized.
Patients, providers, and officials in public health and government can find useful information regarding monoclonal antibodies, which can help prevent severe outcomes from COVID-19. Find out who is eligible, where to find sites, and how to access these critical treatments.
The most urgent task for those of us managing crises like COVID-19 is protecting those most vulnerable to its harmful, and often, fatal outcomes.
July 27, 2021 / Press Release
June 29, 2021 / News
June 28, 2021 / News